CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease Medical Therapy for CTEPH: Is There Still Space for More? Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension

LetterVolume 12, Issue 8, April 2019

JOURNAL:JACC Cardiovasc Interv. Article Link

Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Yaylali YT, Basarici I. Keywords: pulmonary artery denervation; pulmonary hypertension

LINK

Please click on the "Article Link" on top right to get further access to this Letter.